0000899243-22-025626.txt : 20220707 0000899243-22-025626.hdr.sgml : 20220707 20220707075710 ACCESSION NUMBER: 0000899243-22-025626 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220705 FILED AS OF DATE: 20220707 DATE AS OF CHANGE: 20220707 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Barton Debora CENTRAL INDEX KEY: 0001936730 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40603 FILM NUMBER: 221070654 MAIL ADDRESS: STREET 1: C/O TSCAN THERAPEUTICS, INC. STREET 2: 830 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TScan Therapeutics, Inc. CENTRAL INDEX KEY: 0001783328 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 825282075 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 830 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 857-399-9500 MAIL ADDRESS: STREET 1: 830 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-07-05 0 0001783328 TScan Therapeutics, Inc. TCRX 0001936730 Barton Debora C/O TSCAN THERAPEUTICS, INC. 830 WINTER STREET WALTHAM MA 02451 0 1 0 0 Chief Medical Officer Stock Option (right to buy) 3.17 2022-07-05 4 A 0 150000 0.00 A 2032-07-04 Voting Common Stock 150000 150000 D The shares subject to this option will vest with respect to 25% of the shares after 12 months of continuous service to the Issuer following July 5, 2022, and the balance will vest in equal monthly installments over the next 36 months of continuous service to the Issuer. /s/ Debora Barton 2022-07-07